Myeloproliferative Neoplasm, BCR-ABL1 Negative

Myeloproliferative Neoplasm, BCR-ABL1 Negative — Trials · CancerIndex

Clinical trials

Registered studies

333 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 50
Ph III recruiting: 7
Growth YoY: —
Industry share: 41%
Top sponsor: City of Hope Medical Center
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05074550	Safety Evaluation Study for Patients With Polycythemia Vera	unknown	Phase 1	6	Perseus Proteomics Inc.INDUSTRY	1	Jul 24, 2023	clinicaltrials
NCT04709458	Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis	unknown	Phase 1	10	Taiga Biotechnologies, Inc.INDUSTRY	2	May 3, 2022	clinicaltrials
NCT01298934